Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark.

​

Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine

disorders.

​

We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.

​

Our mission is to serve the growing needs of both patients and practitioners.